Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: January 2012

Chapter 131 - Congenitalheart disease

from Part 24 - Pediatric Anesthesia

Related content

Powered by UNSILO

Suggested readings

Adult Congenital Heart Association Web site. Available at
American Society of Anesthesiologists (ASA) 2005 Annual Meeting Refresher Course Lectures, Perioperative Issues in Patients with Congenital Heart Disease.
EmmanouilidesGC, AllenHD, RiemenschneiderTA, GutgesellHP (eds.). Clinical Synopsis of Moss and Adam's Heart Disease in Infants, Children and Adolescents Including the Fetus and the Young Adult. 1st ed. Baltimore: Williams & Wilkins; 1998.
HoffmanJIE, KaplanS. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890–1900.
HuntingtonJH, MalviyaS, Voepel-LewisT, et al. The effect of a right-to-left intracardiac shunt on the rate of rise of arterial and end-tidal halothane in children. Anesth Analg 1999; 88:759–762.
LakeCL, BookerPD (eds.). Pediatric Cardiac Anesthesia. 4th ed. Baltimore: Lippincott, Williams & Wilkins; 2005.
LovellAT. Anaesthetic implications of grown-up congenital heart disease. Br J Anaesth 2004; 93(1):129–139.
MavroudisC (ed.). Pediatric Cardiac Surgery. 3rd ed. St. Louis: Mosby; 2003.
MillerRD (ed.). Miller's Anesthesia. 6th ed. Burlington, MA: Elsevier; 2005.
MotoyamaEK, DavisP (eds.). Smith's Anesthesia for Infants and Children. 7th ed. St. Louis: Mosby; 2006.
MurphyJG et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990; 323(24):1645–1650.
NicholsDG, CameronDE. Critical Heart Disease in Infants and Children. 2nd ed. Philadelphia: Mosby-Elsevier; 2006.
ParkMK. Pediatric Cardiology for Practitioners, 4th ed. St. Louis: Mosby; 2002.
Prevention of Infectious Endocarditis: Guidelines from the American Heart Association: A Guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736–1754.
RivenesSM, LewinMB, StayerSA, et al. Cardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology 2001; 94:223–229.
RussellIA, HanceWCM, GregoryG, et al. The safety and efficacy of sevoflurane anesthesia in infants and children with congenital heart disease. Anesth Analg 2001; 92:1152–1158.
SarnerJ, LevineM, DavisPJ, et al. Clinical characteristics of sevoflurane in children: a comparison with halothane. Anesthesiology 1995; 82:38–46.
StraffordMA. Management of the patient with repaired or palliated congenital heart disease. In: CotéCJ, TodresID, GoudsouzianNG, RyanJF, eds. A Practice of Anesthesia for Infants and Children. 3rd ed. Philadelphia: Saunders-Elsevier; 2001.
WilliamsGD, JonesTK, HansonKA, MorrayJP. The hemodynamic effects of propofol in children with congenital heart disease. Anesth Analg 1999; 89:1411–1416.